期刊名称：HUMAN FERTILITY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Human Fertility is a leading international, multidisciplinary journal dedicated to furthering research and promoting good practice in the areas of human fertility and infertility. Topics included span the range from molecular medicine to healthcare delivery, and contributions are welcomed from professionals and academics from the spectrum of disciplines concerned with human fertility.
The journal also provides a forum for the publication of peer-reviewed articles arising out of the activities of the British Fertility Society, the British Infertility Counselling Association, the Royal College of Nursing Fertility Nurses Group, the Association of Clinical Embryologists and the British Andrology Society.
All submissions are welcome. Articles considered include original papers, reviews, policy statements, commentaries, debates, correspondence, and reports of sessions at meetings. The journal also publishes refereed abstracts from the meetings of the constituent organizations.
Peer Review Policy:
All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous reviewing by independent reviewers.
Abstracting & Indexing
Human Fertility is covered by the following abstracting, indexing and citation services: Science Citation Index, CAB Abstracts, CAB Health, Cambridge Scientific Abstracts, Chemical Abstracts, CINAHL (Cumulative Index to Nursing And Allied Health Literature), Elsevier EMBASE and Index Medicus (MEDLINE).
Instructions to Authors
Human Fertility publishes original papers, reviews, policy statement, commentaries, correspondence and reports of meetings. Refereed abstracts from the meetings of the constituent organisations are also published. Articles will usually be no longer than 2,500 words although, where merited, longer submissions will be considered. Manuscripts are welcomed from any country although the language of the Journal is UK English. The scope of the Journal is multidisciplinary. Topics included span the range from molecular medicine to healthcare delivery in relation to research and practice in the areas of human fertility and infertility.
All contributions will be anonymously reviewed by referees nominated by members of the Editorial Board. Decisions regarding publication will be made by the Editors with advice from the Editorial Board, and feedback will be provided to authors on decisions taken. The ultimate decision on publication lies with the Editor-in-Chief.
Submission of manuscripts
All submissions should be made online at Human Fertility’s submission service at: http://mc.manuscriptcentral.com/thuf. New users should first create an account. Once a user is logged onto the site submissions should be made via the Author Centre.
Manuscripts should be accompanied by a letter stating that the work has not been and will not be submitted for publication elsewhere until a decision is made about the publication of the paper. Three copies of papers quoted as ’in press’ in the reference list must be provided for the referees. Authors may give the names (if possible with the addresses, telephone and fax numbers and email addresses) of up to three experts working in the field of study of the paper. These experts may be asked to referee the paper. The Editorial Assistant is not responsible for loss or damage to manuscripts and illustrations.
Preparation of manuscripts
Manuscripts should be typed double-spaced throughout (including reference list and figure legends) with at least 2 cm margins on all sides. If possible, MS Word should be used, and text only version of the file should be included. The text should be keyed in the Journal style; this is particularly important for the Reference sections and for the difference levels of headings. All media should be screened for viruses. Spelling should conform to the Oxford English Dictionary. Pages should be numbered and manuscripts should be arranged in the following order: Title page, Summary, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Figure legends and Figures. All abbreviations should be defined when first mentioned.
To assist bibliographical services, a list of up to six keywords should be supplied, as well as a summary abstract of up to 200 words.
Abstract
The abstract, a single paragraph of not more than 200 words, should state the objective of the study and the methods used and should summarize results and conclusions. Abbreviations and references are not allowed.
Introduction
The introduction should set the study in context by briefly reviewing relevant knowledge of the subject. This should be followed by a concise statement of the objectives of the study.
Materials and Methods Ethics of experimentation
Human subjects: Authors should indicate in the text that investigations have been approved by the local ethical committee and that consent has been obtained from patients.
Animals: Experiments with animals should be performed in accordance with UK legal requirements. Details of procedures and anaesthetics used and doses given should be provided. The breed or strain and source of animals should be stated and details of age, weight, sex and housing should be provided.
Methods
Sufficient information should be provided so that other workers can repeat the study. If well-established methods are used, a reference to the technique should be given, but full details of any modifications should be provided. The source of chemicals, reagents and hormones should be stated and the manufacturer’s name and location (town) should be given in parentheses. The generic name, dose and route of administration should be given for drugs. The composition of buffers, solutions and culture media should be specified. SI symbols must be used. Concentrations should be given in mol l-1. For international units iu should be used (U should be used for enzyme activity). For solutions, the term % must be defined as w/v or v/v.
Statistical analyses
Authors should give sufficient details of the experimental design and analysis so that the reader can assess their adequacy and validity. In particular, the numbers of experimental units used and the way in which they have been allocated to treatments should be described. If observations have been omitted from the analysis this must be justified. Methods of analysis should be described precisely and any necessary assumptions stated clearly because these may affect the conclusions that can be drawn from the experiment.
Results
Results should be presented in text, tables and figures as appropriate. Data given in tables and figures should not be repeated in the text. Tables and figures should be cited in the text in numerical order.
Discussion
The interpretation of results should be discussed, observations should be related to relevant studies and the implications of results for future research should be outlined. Results should not be repeated in this section.
Acknowledgement
Acknowledgement of technical help and of financial and material support may be mentioned in this section.
Declaration of interest
It is the policy of all Informa Healthcare to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/index.html#conflict).
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organisation with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers' bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.
All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and, where available, within the appropriate field on the journal's Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.
If no conflict is declared, the following statement will be attached to all articles:
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgements on conclusions drawn.
Referencing
Please ensure that all references cited in the text are included in the reference list and vice versa. The reference list should contain only articles that are accessible to most scientists.
Unpublished work, including personal communications, manuscripts in preparation and manuscripts submitted but not yet accepted for publication, should be referred to in the text in the following way: (A. Stone, unpublished), (J. Brown, personal communication). It is the responsibility of the author to obtain permission from colleagues to include their work as a personal communication. Articles that are accepted for publication but are not yet published may be listed as ‘in press’ in the reference list.
In text. References should be cited in chronological order and et al. should be used for more than two authors, for example: (Davies & Smith, 1996; Frost et al., 1997; Williams, 1997).
In reference list. References should be cited in alphabetical order. Papers by the same author should be given in the order (i) single author (ii) two authors alphabetically according to the name of the second author (iii) three or more authors chronologically, with (a) (b) and (c) etc. for papers published in the same year, in the order in which they are cited in the text. References to articles in journals should include authors’ names with initials, year of publication, full title of article, journal title given in full, volume number, and first and last page numbers. References should be in the format of the following example:
Davis, C.J., Davison, R.M., & Conway, G.S. (1998). Genetic basis of premature ovarian failure. Human Fertility, 1, 20–22.
Reference to books should include authors' names, year of publication, chapter title, book title, edition number, page numbers, names of editors, name of publisher and city of publication, for example:
Byskov, A.G. & Hoyer, P.E. (1994). Embryology of mammalian gonads and ducts. In E. Knobil & J.D. Neill (Eds), The Physiology of Reproduction (pp 75–86). New York: Raven Press
References to television programmes, reports, etc. should provide as much information as possible (for example, date and time of transmission and channel).
Tables
Tables should be concise and informative. The title should be a single sentence typed at the head of the table and should include the name of the organism studied. Any additional explanatory material should appear as footnotes cross-referenced to the column entries. Tables should be self-contained, ie, not requiring further explanation; they should be numbered (arabic numbers) and cited in the text. All abbreviations used in the table must be explained in the footnotes. Each column should have a short heading. Internal horizontal and vertical rules should not be used.
Figures
Each figure should be submitted on a separate sheet or as separate image files. Sections of figures should be labelled as (a) (b) etc. in the top left-hand corner. Eps files (saved with a preview) are preferred; files should be exported in Illustrator format. If Photoshop (tiff or jpeg) files are supplied, images should be saved with an image resolution of at least 300 DPI for the printer to be able to reproduce them in a legible format.
Line drawings
Originals should be double the size of eventual reproduction. Symbols should be large enough to be clearly visible when the figure is reduced for publication. Figures should not be enclosed in boxes.
Colour Figures
Any figure submitted as a colour original will appear in colour in the journal’s online edition free of charge and can be downloaded. Paper copy colour reproduction will only be considered on condition that authors contribute to the associated costs. Charges are: £500/US$1030 for the first colour page and £250/US$515 for each colour page after per article. (Colour costs will be waived for invited Review Articles)
Figure legends
Legends describing the figures and giving keys to any symbols used should be submitted on a separate sheet, or entered when uploading files if separate from main document file. The name of the organism studied should be included and all abbreviations used in the figure should be explained in the legend.
Copyright
It is a condition of publication that authors vest or license copyright in their articles, including abstracts, in the named Society that holds the copyright. This enables us to ensure full copyright protection and to disseminate the article, and the journal, to the widest possible readership in print and electronic formats as appropriate. All material should conform to the uniform requirements for manuscripts submitted to biomedical journals (Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med 1997;126:36-47). Authors will normally be entitled to publish any part of their paper elsewhere provided permission is requested and the usual acknowledgements are given. The assignment of the copyright will not affect subsisting patent rights or arrangements relating to them. Illustrations, tables or quotations from other publications are already copyrighted and can be reproduced only with written permission from the copyright owner. Written permission to use these should accompany the manuscript.
Offprints and Reprints
Offprints and reprints of articles published in this journal can be purchased once the article has been published online. Corresponding authors will receive free online access to their article through our website. Reprints of articles published in this journal can be purchased through Rightslink® when proofs are received. Copies of the Journal can be purchased at the authors’preferential rate of £15.00/$25.00 per copy.
Randomised Clinical Trials
Authors are required to adhere to the guidelines for Randomised Clinical Trials (RCT). These can be found at the CONSORT (CONsolidated Standards Of Reporting Trials) website. The main product of CONSORT is the CONSORT Statement, which is an evidence-based, minimum set of recommendations for reporting RCTs. The CONSORT Statement comprises a 22-item checklist and a flow diagram, along with some brief descriptive text. The checklist items focus on reporting how the trial was designed, analyzed, and interpreted; the flow diagram displays the progress of all participants through the trial. Both of these can be found on the website, and should be included when the article is submitted. Authors are asked to refer to the CONSORT website each time they make a new submission as the CONSORT statement is subject to periodic changes as new evidence emerges.
Clinical Trials Registry
Human Fertility recommends, as a consideration of publication, that clinical trials are registered in a public repository at their inception and prior to patient enrolment.
The registry must be accessible to the public at no charge, be open to all prospective registrants and managed by a not-for-profit organization. For a list of registries that meet all of these requirements, please see the WHO International Clinical Trials Registry Platform (ICTRP) http://www.who.int/ictrp/en/. This is in accordance with the guidelines published by the International Committee of Medical Journal Editors (ICMJE). For more information, see ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals http://www.icmje.org
The registration of all clinical trials facilitates the dissemination of information among clinicians, researchers and patients, and enhances public confidence in the research enterprise.
NIH Public Access Policy
In consideration of the National Institutes of Health (NIH) Public Access Policy, Informa Healthcare acknowledges that the broad and open dissemination of NIH-funded-research results may benefit future scientific and medical research. Because we value the current and future contributions our journals make to the scientific body of knowledge, we have made certain that our policies accommodate those authors who wish to submit to PubMed Central.
Informa Healthcare's position with respect to public access to NIH-funded work published in Informa Healthcare journals is as follows:
- Informa Healthcare authors may voluntarily submit their funded work to PubMed Central after a 12-month embargo period;
- “funded work” shall be defined as the final, peer-reviewed manuscript that is accepted by the Editor in Chief of the journal. This manuscript must not be altered by Publisher's copyediting and typesetting services; and
- this embargo period begins the day the work is published online on our website.
Editorial Board
Editor-in-Chief:
Professor Henry Leese - Hull York Medical School, UK
Clinical Sub-editor: Dr Jane A Stewart - Newcastle Fertility Centre at LIFE, UK
Science Sub-editor: Dr Allan Pacey - Unviersity of Sheffield, UK
Nursing, Counselling and Ethics Sub-editor: Mrs Jane Denton - Multiple Births Foundation, UK
Health and Social Sciences Sub-editor: Dr Sarah Earle - The Open University, UK
Editorial Board:
Dr Virginia Bolton - Guy's and St Thomas' NHS Foundation Trust, London, UK
Dr Martin Brinkworth - University of Bradford, UK
Dr Daniel Brison - St Mary’s Hospital, Manchester, UK
Dr Mark Hamilton - Maternity Hospital, Aberdeen, UK
Professor Roger Hart - University of Western Australia, Australia
Dr David Miller - University of Leeds, UK
Dr Stella Milsom - Fertility Associates, Ascot Hospital, Auckland, New Zealand
Dr Jim Monach - University of Sheffield, UK
Dr Aonghus Nolan - Galway Fertility, Eire
Dr Edgar Mocanu- Rotunda Hospital , Dublin, Ireland
Professor Sergio Oehninger - Eastern Virginia Medical School, Virginia, USA
Mr Anthony Rutherford - Leeds General Infirmary, Leeds, UK
Dr Denny Sakkas - Yale University School of Medicine, USA
Professor Andrew Shelling - University of Auckland, New Zealand
Dr Bryan Woodward - London Fertility Centre, UK
Associate Members:
David Jennings - Regional Fertility Centre, Royal Maternity Hospital,Belfast, Northern Ireland
Kate Brian- British Infertility Counselling Association 33 Goldington St., London NW1 1UE, UK
Karen Ralph - University Hospital, Southampton, UK
International Advisory Board:
Professor Adam Balen - Leeds General Infirmary, Leeds, UK
Dr Ashok Agarwal - Cleveland Clinic, USA
Debbie Barber - John Radcliffe Maternity Hospital, Oxford, UK
Professor Ariff Bongso - National University of Singapore, Singapore
Professor Ken Daniels - University of Canterbury, New Zealand
Dr Johan Hazekamp - Volvat Medical Center, Oslo, Norway
Dr Brian Lieberman - St. Mary’s Hospital, Manchester, UK
Dr Gillian Lockwood - Midland Fertility Services, Aldridge, UK
Dr Catherine Racowsky - Brigham and Women’ and Harvard Medical School, Boston, USA
Professor Lesley Regan - Imperial College, London, UK
Professor Mary Renfrew - University of York, UK
Dr Lone Schmidt - University of Copenhagen, Denmark
Dr Jeremy Thompson - University of Adelaide, Australia
Editorial Office: Hull York Medical School
Hertford Building
University of Hull
Hull, HU6 7RX, UK
Dr Sandra Downing
Editorial Assistant
Email: biol103@york.ac.uk
|
刊名字顺( Alphabetical List of Journals):
返回页首 